News

Fundstrat's Granny Shots ETF Milestone: $3B AUM Growth Achieved

Fundstrat's Granny Shots ETF Milestone: $3B AUM Growth Achieved

Fundstrat Capital’s Granny Shots ETF Hits $3 Billion Mark

Fundstrat Capital's Granny Shots U.S. Large-Cap ETF (NYSE: GRNY) has recently celebrated a significant milestone by surpassing $3 billion in assets under management (AUM). This remarkable achievement was reached shortly after the ETF’s inception in November the previous year, showcasing its rapid growth trajectory and solid investor interest.

Impressive Year-to-Date Performance

As of the latest market updates, Fundstrat's actively managed ETF recorded an outstanding year-to-date increase of 26.54%. This performance stands in stark contrast to the benchmark S&P 500 Total Return Index, which only rose by 15.30%. The impressive outperformance is quantified by a difference of 1,124 basis points, further establishing GRNY’s position as a leader among equity ETFs.

Growth Since Inception

Since its launch on November 7, 2024, the Granny Shots ETF has garnered a cumulative increase of 26.29%, while the S&P 500 merely recorded a 14.65% rise during the same period. Such results represent an outperformance of 1,163 basis points, capturing the attention of investors looking for stable, growth-oriented investments.

Investor Interest and Market Reception

Thomas "Tom" Lee, Chief Investment Officer and Lead Portfolio Manager at Fundstrat Capital, expressed the firm's enthusiasm regarding the positive response from investors. He noted the ETF's strong performance and the thematic-focused rationale that resonates with investors, along with robust communication strategies that include videos and newsletters aimed at investor education.

Team Effort Behind Success

Ken Xuan, a Portfolio Manager at Fundstrat Capital, emphasized the team-oriented nature of the ETF's success. He acknowledged that the swift accumulation of investor assets is a significant validation of the investment strategies they employ, signaling that a multi-thematic approach is appealing to today’s investors.

Core Investment Philosophy

The Granny Shots ETF, aptly named to represent its focus on quality, aims to invest in the highest-quality stocks within the S&P 500, typically around 35 companies. The selection process hinges on identifying critical thematic arcs expected to impact the market over the next five to ten years. Key themes include navigating global labor shortages, ensuring cyber and energy security, understanding the millennial consumer demographic, and considering monetary policy cycles.

Understanding the Investment Landscape

The investment approach taken by Fundstrat’s team is rigorous and research-driven. They remain focused on ensuring that at least two of their identified themes anchor their stock selections, thus allowing investors to tap into relevant market trends while still maintaining a solid foundation in quality companies.

Performance Data Insights

Current performance metrics are indicative of past achievements and should serve as a prospective measure for future performance. However, it’s important for potential investors to note that investment returns and principal value can fluctuate significantly. Shares redeemed may carry different values than when they were initially purchased. Therefore, staying informed through the fund's updates is crucial.

Investors should carefully evaluate the fund's objectives, risks, charges, and expenses prior to making an investment choice. Detailed information can typically be found in the prospectus, which is an essential reading for those considering investment options.

Risks Involved in Equity Investment

Investing in equity markets inherently comes with risks that potential investors must acknowledge. Common stock investments pose higher risks compared to preferred stocks or debt obligations due to the variable nature of stockholder rights in claims against issuers.

Understanding Market Mechanisms

Fundamentally, investment models and data are crucial to the ETF’s performance yet can sometimes lead to inaccuracies if based on flawed information. Operational risks, including human errors and technological malfunctions, also pose challenges, making it vital for prospective investors to understand these underlying factors.

Final Thoughts on GRNY ETF

The Granny Shots ETF illustrates a promising avenue for investors seeking exposure to thematic growth in the equity market. Fundstrat Capital's innovative strategies and commitment to quality investment options position them favorably in the competitive ETF landscape.

Frequently Asked Questions

What is the Granny Shots ETF?

The Granny Shots ETF is an actively managed investment fund designed to invest in high-quality U.S. large-cap stocks while focusing on emerging market themes.

How has the ETF performed year-to-date?

As of the latest reports, the ETF has achieved a 26.54% increase year-to-date, outperforming the S&P 500 by a significant margin.

What themes does the Granny Shots ETF target?

It targets several key themes, including labor shortages, cybersecurity, energy security, millennials, and monetary policy shifts.

What should investors consider before investing?

Investors must consider the fund’s objectives, risks, past performance, and expenses as outlined in the prospectus.

How can I learn more about the ETF’s performance?

Detailed performance can be tracked through regular updates available on Fundstrat’s official website and their communications channels.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Hydden Welcomes Cybersecurity Veteran Charles Tango as CSO

Updated Category News Views 26

Unpacking Charles Tango's Move to Hydden Nobody expects cybersecurity to be a stroll in the park, and it looks like Hydden just upped its game by bringing in Charles Tango, a heavyweight turned strategy guru. You might not know him, but this guy's got a track record that shouldn’t be ignored—like a grizzled old prizefighter just itching for a new opponent. A Veteran...

Continue Reading
Kaolin Market Surges to $8.89B by 2031: Key Trends

Updated Category News Views 75

Riding the Kaolin Wave: Industrial Market Expansion You can't miss the sound of kaolin clinking in as it rides the tide of industrial demand. Reports from MarketsandMarkets™ have kaolin's party rocking all the way to a hefty $8.89 billion by 2031, up from $6.19 billion in 2026. With a sensible 7.5% compound annual growth rate (CAGR), this clay’s is aiming for the...

Continue Reading
Laser Weapon Market to Double: Military Demand Surges

Updated Category News Views 96

Pew Pew: Lasers Are the Future of Defense Forget lightsabers, we've got something even flashier—a market that's going to double in worth by 2035. High-energy laser weapons are coming in hot, growing from USD 2.17 billion in 2026 to an estimated USD 4.54 billion by the end of 2035. That's no small potatoes! What's Driving This Beam Dream? The military is all about upping...

Continue Reading
Coretek Joins CRN's Elite AI Innovators of 2026

Updated Category News Views 93

Coretek's Leap to AI Innovator Status Here we are, folks. Another announcement hits the wires that showcases a company's ascent amid the swelling AI tide. Coretek, hailing from Farmington Hills, managed to snag a spot on CRN's inaugural 2026 AI Innovators list. No small potatoes, if you ask me, considering the competition on this playing field. Why the fuss? It's about...

Continue Reading
Segway Powersports Charges Ahead with MY27, iFUN 2.0

Updated Category News Views 32

Rolling Out Power and Tech at EICMA 2026 A real gearhead's delight rolled out at EICMA 2026, with Segway Powersports lighting up the stage showcasing their 2027 upgrades. If you're betting on somewhere as time-honored for two- and four-wheeling wonders as EICMA, you know stakes get real high. Segway's making noise with their MY27 lineup and a next-gen iFUN 2.0, aiming to...

Continue Reading
Askey & Icom Team Up: Trading Airwaves for Partnerships

Updated Category News Views 28

Old-School Radios Meet Cutting-Edge 5G When I hear about a company linking their old-school tech with shiny new 5G jazz, skepticism kicks in fast. But then comes this announcement: Askey and Icom America are joining forces to bring 5G networks with integrated two-way radio systems to various sectors—like a classic combo meal with a tech twist. The key audience? Utility...

Continue Reading
NOVOS Trial Boosts Vascular Health: A New Horizon

Updated Category News Views 72

Watch Out, Aging: NOVOS Is Making Waves Aging ain't what it used to be, and longevity's becoming the golden chalice of the wellness world. Surrounded by a sea of questionably effective supplements, NOVOS, a biotech firm focused on prolonging the healthy years of life, steps up with some hard evidence. Their STAMINA trial, published in the European Heart Journal Open,...

Continue Reading
Minghui and ASKA Seal Major Licensing Deal for MHB018A

Updated Category News Views 187

Breaking New Ground in Thyroid Eye Disease Treatment If there's one thing that keeps the biopharma world on its toes, it's the relentless pursuit of groundbreaking treatments. And folks, let me tell you, the latest tie-up between Minghui Pharmaceutical and ASKA Pharmaceutical has struck a chord. This union with MHB018A at its core might be one of those watershed moments...

Continue Reading
A2Gold Tackles Tough Terrain at Eastside Project

Updated Category News Views 96

Drilling Challenges and Initial Observations Folks, it's a roller coaster out there—A2Gold just wrapped up a gritty round of drilling at their Eastside Gold-Silver Project near Tonopah, Nevada. They've punched through five reverse circulation (RC) holes, totaling 1,936 meters, all while battling tough conditions. You could say they've truly earned their stripes in the...

Continue Reading
HashKey and AMBR Unite to Push AI Frontiers in Finance

Updated Category News Views 53

Shaping the Future with AI Integration In the whirlwind of innovation, there's always the ones braving the frontier, pushing the very boundaries of what we deem possible. Today, it's HashKey Capital and AMBR joining forces, marching into uncharted financial territories. This partnership is more than just a signature on a piece of paper; it's a declaration—a commitment...

Continue Reading

Top 5 Most Recently Viewed Articles

Michelle Fermin Earns Place in Century 21 Hall of Fame

Updated Category News Views 139

Michelle Fermin Inducted into the Hall of Fame In a remarkable recognition of her contributions to the real estate industry, Michelle Fermin from CENTURY 21 North East has been inducted into the prestigious Century 21 Dick Loughlin International Hall of Fame. This prestigious honor was announced during a recent Top Agent Retreat, showcasing her dedication and commitment...

Continue Reading
Hallador Energy Secures Path to Expand Natural Gas Capacity

Updated Category News Views 90

Hallador Energy's Strategic Move into Natural Gas Hallador Energy Company (Nasdaq: HNRG) has made significant strides lately by finalizing its application for the Expedited Resource Addition Study (ERAS) program. The application, crucial for its expansion into natural gas power generation, includes deposits totaling around $13 million, setting the stage for impressive...

Continue Reading
Transforming Sales with Innovative AI Strategies for Growth

Updated Category News Views 304

Revolutionizing Enterprise Sales with Cutting-Edge AI Across AI is setting a new standard for enterprise workflows by introducing next-generation agentic AI technology for sales teams. This innovative startup has secured significant seed funding to launch its groundbreaking AI-supported system designed to optimize sales processes. With funding led by prominent venture...

Continue Reading
Rayonier Reveals Special Dividend Election Results and Details

Updated Category News Views 256

Rayonier Inc. Special Dividend Election Update Rayonier Inc. (NYSE: RYN), a prominent player in the timberland sector, has recently shared important updates regarding its special dividend elections. This announcement will provide insights into shareholder options and the mechanics behind the forthcoming dividend distribution. The Company has set a dividend amount of $1.80...

Continue Reading
Strategy Inc. Aims for $21 Billion in Preferred Stock Offering

Updated Category News Views 155

Strategy Inc. Unveils Major Fundraising Initiative Strategy Inc. (NASDAQ: MSTR) has made headlines by announcing its intention to offer a substantial $21 billion in preferred stock. This bold move aims to gather necessary funds to bolster its ongoing strategy focused on Bitcoin acquisitions. By capitalizing on the cryptocurrency's growing popularity, the company seeks to...

Continue Reading